Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan
· Delayed Price · Currency is TWD 27.80
-0.10 (-0.36%)
At close: Apr 29, 2026
Formosa Pharmaceuticals Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 241.79 | 425.79 | 384.71 | 267.34 | 208.92 | Upgrade
|
| Short-Term Investments | 1,200 | 1,220 | 831.41 | 153.55 | - | Upgrade
|
| Cash & Short-Term Investments | 1,442 | 1,646 | 1,216 | 420.89 | 208.92 | Upgrade
|
| Cash Growth | -12.39% | 35.33% | 188.94% | 101.46% | 398.99% | Upgrade
|
| Other Receivables | 25.7 | 51.66 | 46.44 | 14.72 | 13.88 | Upgrade
|
| Receivables | 25.7 | 51.66 | 46.44 | 14.72 | 13.88 | Upgrade
|
| Inventory | 4.17 | 2.89 | - | - | - | Upgrade
|
| Prepaid Expenses | 44.12 | 26.94 | 25.34 | 20.57 | 11.66 | Upgrade
|
| Other Current Assets | 0.16 | 0.52 | 0.44 | 0.13 | 0.04 | Upgrade
|
| Total Current Assets | 1,516 | 1,728 | 1,288 | 456.31 | 234.5 | Upgrade
|
| Property, Plant & Equipment | 43.56 | 29.89 | 34.36 | 10.18 | 8.19 | Upgrade
|
| Long-Term Investments | 1.54 | 5.15 | 27.26 | - | - | Upgrade
|
| Goodwill | 30.54 | 30.54 | 30.54 | 30.54 | 30.54 | Upgrade
|
| Other Intangible Assets | 431.77 | 311.85 | 345.64 | 380.2 | 414.83 | Upgrade
|
| Other Long-Term Assets | 47.89 | 7.05 | 0.65 | 0.67 | 0.65 | Upgrade
|
| Total Assets | 2,071 | 2,112 | 1,727 | 877.91 | 688.72 | Upgrade
|
| Accounts Payable | 0.77 | - | - | - | - | Upgrade
|
| Accrued Expenses | 89.74 | 128.36 | 86.67 | 66.09 | 7.17 | Upgrade
|
| Current Portion of Leases | 6.57 | 5.5 | 5.5 | 2.5 | 2.76 | Upgrade
|
| Current Unearned Revenue | 21.29 | 4.51 | 71.33 | - | - | Upgrade
|
| Other Current Liabilities | 48.04 | 59.59 | 94.48 | 0.98 | 9.37 | Upgrade
|
| Total Current Liabilities | 166.42 | 197.95 | 257.98 | 69.57 | 19.3 | Upgrade
|
| Long-Term Leases | 20.41 | 20.3 | 24.29 | 4.41 | 0.42 | Upgrade
|
| Long-Term Unearned Revenue | 16.76 | 23.48 | 1.66 | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 3.46 | 3.95 | 4.45 | 4.94 | 5.43 | Upgrade
|
| Other Long-Term Liabilities | 407.02 | 318.02 | 297.84 | 331.6 | 270.33 | Upgrade
|
| Total Liabilities | 614.06 | 563.7 | 586.21 | 410.51 | 295.48 | Upgrade
|
| Common Stock | 1,510 | 1,510 | 1,341 | 1,136 | 988.32 | Upgrade
|
| Additional Paid-In Capital | 2,279 | 2,279 | 1,780 | 978.52 | 620.49 | Upgrade
|
| Retained Earnings | -2,237 | -2,153 | -1,952 | -1,630 | -1,202 | Upgrade
|
| Comprehensive Income & Other | -95.74 | -87.59 | -29.91 | -18.14 | -14.53 | Upgrade
|
| Total Common Equity | 1,457 | 1,548 | 1,140 | 466.83 | 392.74 | Upgrade
|
| Minority Interest | 0.55 | 0.59 | 0.54 | 0.57 | 0.49 | Upgrade
|
| Shareholders' Equity | 1,457 | 1,549 | 1,141 | 467.4 | 393.23 | Upgrade
|
| Total Liabilities & Equity | 2,071 | 2,112 | 1,727 | 877.91 | 688.72 | Upgrade
|
| Total Debt | 26.99 | 25.8 | 29.79 | 6.9 | 3.18 | Upgrade
|
| Net Cash (Debt) | 1,415 | 1,620 | 1,186 | 413.99 | 205.74 | Upgrade
|
| Net Cash Growth | -12.67% | 36.55% | 186.56% | 101.22% | 476.99% | Upgrade
|
| Net Cash Per Share | 9.37 | 11.50 | 9.56 | 3.94 | 2.22 | Upgrade
|
| Filing Date Shares Outstanding | 150.98 | 150.98 | 134.14 | 113.64 | 98.83 | Upgrade
|
| Total Common Shares Outstanding | 150.98 | 150.98 | 134.14 | 113.64 | 98.83 | Upgrade
|
| Working Capital | 1,350 | 1,530 | 1,030 | 386.75 | 215.2 | Upgrade
|
| Book Value Per Share | 9.65 | 10.25 | 8.50 | 4.11 | 3.97 | Upgrade
|
| Tangible Book Value | 994.31 | 1,206 | 763.85 | 56.09 | -52.64 | Upgrade
|
| Tangible Book Value Per Share | 6.59 | 7.99 | 5.69 | 0.49 | -0.53 | Upgrade
|
| Machinery | 23.76 | 8.14 | 7.38 | 7.44 | 7.44 | Upgrade
|
| Leasehold Improvements | 0.7 | 0.7 | 0.45 | 1.54 | 1.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.